Rhythm Technologies (Nasdaq: IRTC) announced results from two large, real-world analyses demonstrating the benefits of its ...

Higher Yield for Non-Daily Symptom Patients: Non-daily symptom patients—those with symptoms occurring with a frequency less than once per day—had an 80.9% arrhythmia yield versus 69.1% in ...